Hoffmann-La Roche Inc. received FDA clearance to sell Pegasys, a pegylated interferon for the treatment of hepatitis C, making it the second drug on the market for this disease developed using ...
Feb. 7, 2005 -- The European Commission has approved an expanded indication for peginterferon alfa-2a injection, allowing its use in the European Union for the treatment of hepatitis C virus in ...
A combination treatment of Pegasys (peginterferon alfa-2a 40kd) a pegylated interferon, with ribavirin, an orally active anti-viral medication, has shown some of the most effective treatment rates yet ...
Most adults clear HBV before it progresses to chronic infection. However, for the patient who develops chronic disease, several medical therapies are available, including both oral and subcutaneous ...
BURLINGTON, Mass.--(BUSINESS WIRE)--In light of the reported global shortage of Pegasys® (peginterferon alfa-2a), PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, reaffirms its ...
CHAPEL HILL -- The New England Journal of Medicine's Sept. 26 issue carries the first published report showing that a combination treatment with peginterferon alfa-2a (Pegasys) - a new long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results